Abstract Body

Background: IRIS is a pathogen-specific inflammatory response associated with ART initiation. We conducted a nested case-cohort study among subjects in a large prospective randomized longitudinal clinical trial (A5202) in the USA and investigated 18 plasma biomarkers of inflammation and microbial translocation for their association with risk of IRIS.

Methods: ACTG A5202 compared ABC/3TC or TDF/FTC combined with ATV/r or EFV for first-line HIV treatment. IRIS events were defined using ACTG criteria; unmasking and paradoxical events were included. 51 of 1452 subjects with baseline CD4<350 cells/mm3 developed IRIS (3.9 cases/100 person years). We analyzed 100 randomly selected subjects (94 non-IRIS, 6 IRIS, stratified by pre-enrollment CD4≤200 cells/mm3) and 45 additional IRIS cases. Plasma samples at baseline (n=141), an early time-point (~week 4, n=138) and week 48 (n=136) were tested for tumor necrosis factor (TNF), sTNF receptor I, sTNF receptor II, granulocyte colony stimulating factor (G-CSF), monocyte chemoattractant protein 1 (MCP-1), interferon (IFN) gamma, IFN alpha 2, IFN gamma inducible protein 10 (IP-10), IL-1 beta, IL-2, IL-6, IL-8, IL-10, IL-12, IL-17, sCD14 (ELISA, Luminex or electrochemiluminescence), lipopolysaccharide (LPS, Limulus amebocyte lysate assay) and 16s ribosomal (r) DNA(PCR).
Cox models, stratified by pre-enrollment CD4 and weighted for the case-cohort design, evaluated associations between baseline biomarkers and time to first IRIS event. Logistic models evaluated associations between biomarker levels at week 4 and 48 and IRIS.

Results: The 145 subjects included 79% male (34% with AIDS history), median age 39 years, baseline HIV-1 RNA 4.8 (IQR 4.6-5.4) log10c/ml, CD4 84 (30-184) cells/mm3.
At baseline, higher IP-10, LPS, sCD14, 16s rDNA and IFN alpha 2 were associated with greater risk of IRIS (Table). There was a significant (p=0.012) non-linear relationship between MCP-1 and IRIS. These results were supported by adjusted models; other biomarkers had p≥0.15.
Most biomarkers (TNF, sTNFRII, G-CSF, MCP-1, IP-10, IL-8, IL-10, IFN alpha 2, LPS, sCD14) decreased after ART initiation. IP-10 and LPS at week 4 were still associated with IRIS. At week 48, this association only remained for IP-10.

Conclusions: Enhanced systemic inflammatory response presumably through persistent monocyte activation and bacterial translocation in immunosuppressed patients appear important in the pathogenesis of IRIS and may be useful to predict risk for IRIS

viewer?TAG_ACTION=SECURE_FILE_DOWNLOAD&V